Supernus Pharmaceuticals, Inc.

MORGAN STANLEY SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,079,471

Value ($000)

53,650

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	53,650	0.0%	1,079,471	12/31/2025
2025 Q3	11/14/2025	36,097	0.0%	755,317	9/30/2025
2025 Q2	8/14/2025	21,867	0.0%	693,752	6/30/2025
2025 Q1	5/15/2025	21,282	0.0%	649,838	3/31/2025
2024 Q4	5/15/2025	24,504	0.0%	677,667	12/31/2024
2024 Q3	5/14/2025	22,640	0.0%	726,113	9/30/2024
2024 Q2	5/14/2025	17,938	0.0%	670,567	6/30/2024
2024 Q1	5/15/2024	22,179	0.0%	650,226	3/31/2024
2023 Q4	2/13/2024	20,934	0.0%	723,355	12/31/2023
2023 Q3	11/15/2023	14,573	0.0%	528,579	9/30/2023
2023 Q2	8/14/2023	16,710	0.0%	555,898	6/30/2023
2023 Q1	5/15/2023	19,596	0.0%	540,885	3/31/2023
2022 Q4	2/14/2023	26,055	0.0%	730,443	12/31/2022
2022 Q3	11/14/2022	17,457	0.0%	515,734	9/30/2022
2022 Q2	10/27/2022	13,710	0.0%	474,029	6/30/2022
2022 Q1	10/27/2022	7,521	0.0%	232,704	3/31/2022
2021 Q4	2/14/2022	8,109	0.0%	278,052	12/31/2021
2021 Q3	11/15/2021	5,995	0.0%	224,757	9/30/2021
2021 Q2	8/23/2021	8,103	0.0%	263,129	6/30/2021
2021 Q1	5/17/2021	5,097	0.0%	194,671	3/31/2021
2020 Q4	2/16/2021	5,751	0.0%	228,561	12/31/2020
2020 Q3	11/13/2020	8,420	0.0%	404,037	9/30/2020
2020 Q2	8/14/2020	14,720	0.0%	619,826	6/30/2020
2020 Q1	5/26/2020	20,546	0.0%	1,142,109	3/31/2020
2019 Q4	2/14/2020	25,478	0.0%	1,074,164	12/31/2019
2014 Q1	5/13/2014	2,735	0.0%	305,877	3/31/2014
2013 Q4	2/13/2014	1,108	0.0%	146,915	12/31/2013